$ENOV

Enovis Corporation reported strong Q1 2026 earnings, surpassing expectations with an EPS of $0.89 against an anticipated $0.82. The company achieved 6% organic revenue growth on a days-adjusted basis, driven by 8% growth in Recon and 3% in Prevention & Recovery. Key drivers included the successful launch and adoption of the Arvis augmented reality system in Recon and continued market share gains in both segments despite a dynamic macroeconomic environment.